Page last updated: 2024-10-24

negative regulation of macrophage apoptotic process

Definition

Target type: biologicalprocess

Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process. [GOC:BHF, GOC:mtg_apoptosis]

Negative regulation of macrophage apoptotic process is a complex biological process that involves a coordinated interplay of signaling pathways, transcription factors, and effector molecules. Macrophages are phagocytic cells of the immune system that play a crucial role in tissue homeostasis and host defense against pathogens. However, excessive macrophage apoptosis can contribute to inflammation and tissue damage. Therefore, tight regulation of macrophage apoptosis is essential for maintaining immune system integrity.

The process of negative regulation of macrophage apoptosis can be initiated by various stimuli, including growth factors, cytokines, and microbial products. These stimuli activate signaling pathways that promote cell survival and inhibit apoptosis.

**Key Signaling Pathways Involved in Negative Regulation of Macrophage Apoptosis:**

* **PI3K/Akt Pathway:** Activation of the PI3K/Akt pathway is a major survival signal in macrophages. PI3K is a lipid kinase that is activated by various stimuli, including growth factors and cytokines. Activated PI3K phosphorylates phosphatidylinositol (4,5)-bisphosphate (PIP2) to produce phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 acts as a docking site for Akt, a serine/threonine kinase. Akt phosphorylation by PI3K activates Akt, which in turn phosphorylates and inhibits pro-apoptotic proteins, such as Bad and caspase-9.
* **NF-κB Pathway:** NF-κB is a transcription factor that plays a crucial role in regulating inflammatory and immune responses. Activation of NF-κB by various stimuli, including TNF-α and LPS, promotes the expression of anti-apoptotic genes, such as Bcl-2 and Bcl-xL. These proteins inhibit the release of cytochrome c from mitochondria, a critical step in the apoptotic cascade.
* **MAPK Pathway:** Mitogen-activated protein kinases (MAPKs) are a family of serine/threonine kinases that are involved in various cellular processes, including apoptosis. Activation of MAPKs, such as ERK, JNK, and p38, can either promote or inhibit apoptosis depending on the specific MAPK pathway involved and the cellular context. In general, activation of ERK promotes survival, while activation of JNK and p38 promotes apoptosis.
* **JAK/STAT Pathway:** The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a major signaling pathway activated by cytokines. Upon cytokine binding to its receptor, JAKs are activated and phosphorylate STAT proteins. Activated STATs dimerize and translocate to the nucleus, where they regulate gene expression, including the expression of anti-apoptotic genes.

**Effector Molecules Involved in Negative Regulation of Macrophage Apoptosis:**

* **Anti-apoptotic proteins:** Bcl-2 family proteins, such as Bcl-2, Bcl-xL, and Mcl-1, are key inhibitors of apoptosis. These proteins localize to mitochondria and prevent the release of cytochrome c, a crucial step in the apoptotic cascade.
* **Inhibitors of caspases:** Caspases are cysteine proteases that play a central role in apoptosis. Caspase inhibitors, such as XIAP and cIAP1/2, bind to and inhibit caspases, thereby preventing the execution of apoptosis.
* **Apoptosis-inducing factor (AIF):** AIF is a mitochondrial protein that can induce caspase-independent apoptosis. However, certain stimuli, such as growth factors and cytokines, can inhibit AIF translocation to the nucleus, thereby preventing apoptosis.

**Regulation of Negative Regulation of Macrophage Apoptosis:**

The process of negative regulation of macrophage apoptosis is tightly regulated to ensure that macrophages survive when needed and undergo apoptosis when appropriate. This regulation is achieved through various mechanisms, including:

* **Crosstalk between signaling pathways:** The various signaling pathways involved in negative regulation of macrophage apoptosis are interconnected and can influence each other's activity. For example, activation of the PI3K/Akt pathway can inhibit the activation of the JNK pathway.
* **Post-translational modifications:** The activity of various proteins involved in negative regulation of macrophage apoptosis can be modulated by post-translational modifications, such as phosphorylation, acetylation, and ubiquitination.
* **Microenvironment:** The surrounding microenvironment can significantly influence the apoptotic fate of macrophages. For example, the presence of pathogens or inflammatory cytokines can promote apoptosis, while the presence of growth factors or cytokines can promote survival.

**Disruption of Negative Regulation of Macrophage Apoptosis in Disease:**

Disruption of the negative regulation of macrophage apoptosis can contribute to various diseases. For example, excessive macrophage apoptosis can contribute to inflammation and tissue damage in diseases such as rheumatoid arthritis, Crohn's disease, and Alzheimer's disease. Conversely, defective macrophage apoptosis can promote tumor growth and metastasis.

**Conclusion:**

Negative regulation of macrophage apoptotic process is a complex and tightly regulated process that is essential for maintaining immune system integrity. This process involves a coordinated interplay of signaling pathways, transcription factors, and effector molecules. Disruption of this process can contribute to various diseases. Therefore, understanding the mechanisms involved in negative regulation of macrophage apoptosis is crucial for developing novel therapeutic strategies for the treatment of these diseases.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Nucleotide-binding oligomerization domain-containing protein 2A nucleotide-binding oligomerization domain-containing protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HC29]Homo sapiens (human)
Growth hormone secretagogue receptor type 1A growth hormone secretagogue receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q92847]Homo sapiens (human)
C-C chemokine receptor type 5A C-C chemokine receptor type 5 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P51681]Homo sapiens (human)
Beta-galactoside alpha-2,6-sialyltransferase 1A beta-galactoside alpha-2,6-sialyltransferase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P15907]Homo sapiens (human)

Compounds (51)

CompoundDefinitionClassesRoles
1,10-phenanthroline1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinasesphenanthrolineEC 2.7.1.1 (hexokinase) inhibitor;
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
2,2'-dipyridyl2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.

2,2'-Dipyridyl: A reagent used for the determination of iron.
bipyridinechelator;
ferroptosis inhibitor
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
terfenadineTerfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.diarylmethane
4,4'-dimethyl-2,2'-bipyridine4,4'-dimethyl-2,2'-bipyridine: structure in first source
5,5'-dimethyl-2,2'-bipyridyl5,5'-dimethyl-2,2'-bipyridyl: structure in first sourcebipyridines
paclitaxelTaxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).taxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
neocuproineneocuproine : A member of the class of phenanthrolines that is 1,10-phenanthroline bearing two methyl substituents at positions 2 and 9.

neocuproine: Spectrophotometric determination of copper and ultramicro blood sugar determinations; structure; RN given refers to parent cpd
phenanthrolineschelator;
copper chelator
2,2',2''-terpyridine2,2',2''-terpyridine: RN given refers to parent cpd

2,2':6',2''-terpyridine : A tridentate heterocyclic ligand that binds metals at three meridional sites giving two adjacent 5-membered MN2C2 chelate rings.
terpyridineschelator
5-methyl-1,10-phenanthroline
3,4,7,8-tetramethyl-1,10-phenanthroline
l 692429L 692429: stimulates release of growth hormone; RN refers to (R)-isomer; structure given in first source
docetaxel anhydrousdocetaxel anhydrous : A tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group.

Docetaxel: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.
secondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
l 163191
tak 779
cp 424391CP 424391: a growth hormone secretagogue; structure in first source
cytidine monophosphate n-acetylneuraminic acidCMP-N-acetyl-beta-neuraminic acid : A nucleotide sugar used as a donor by glycosyltransferases for the synthesis of sugar chains

Cytidine Monophosphate N-Acetylneuraminic Acid: A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein.
CMP-N-acyl-beta-neuraminic acidmouse metabolite
muramyl dipeptideglycopeptideimmunological adjuvant
3-methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dioneoxopurine
3-methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dioneoxopurine
1-(4-methylphenyl)sulfonyl-2-benzimidazolaminesulfonamide
1-(4-chlorophenyl)sulfonyl-2-benzimidazolaminesulfonamide
aplavirocaplaviroc: a spiro-diketo-piperazine; a potent noncompetitive allosteric antagonist of the CCR5 receptor with concomitantly potent antiviral effects for HIV-1; structure in first source
maraviroctropane alkaloid
vicrivirocvicriviroc: structure in first source(trifluoromethyl)benzenes
1-(benzenesulfonyl)-2-benzimidazolaminesulfonamide
1-(4-nitrophenyl)sulfonyl-2-benzimidazolaminesulfonamide
tak-220TAK-220: structure in first source
cp 481715quinoxaline-2-carboxylic acid (4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyloctyl)amide: a CCR1 antagonist and NSAID; structure in first source
pd 166285
ancrivirocAncriviroc: CCR5 receptor antagonistaromatic carboxylic acid;
pyridinemonocarboxylic acid
variecolinvariecolin: structure in first sourceenal;
sesterterpenoid
Aspergillus metabolite
hexarelinhexarelin: a synthetic growth hormone releasing peptide; structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more potent & stable and less toxic than GHRP-6
ucb 35625UCB 35625: J-113863 is the (trans)-isomer; structure in first source
sm 130686SM 130686: a growth hormone secretagogue; structure in first source
macimorelin
tabimorelintabimorelin: a growth hormone secretagogue; structure in first source
l 162752
sk&f 110679
amd 070mavorixafor: a derivative of AMD3100; a CXCR4 blockeraminoquinoline
cenicriviroccenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).

cenicriviroc: an inhibitor of HIV-1
aromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide
anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist
ulimorelinulimorelin: ghrelin agonist; an 18-membered macrocycle containing 3 amide bonds and a secondary amine as well as 4 stereogenic centers; belongs to macrocyclic peptidomimeticsoligopeptide
n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamineN-(3-fluorophenyl)-1-((4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine: a small molecule motilin receptor agonist; structure in first sourceacetamides
yil 781YIL 781: an appetite suppressant and weight loss promoter; structure in first source
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolaminesulfonamide
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolaminesulfonamide
nitd 609NITD 609: an antimalarial and coccidiostat; structure in first source
19,20-epoxycytochalasin q19,20-epoxycytochalasin Q: from Xylaria sp.; structure in first source
gsk 2334470GSK 2334470: a PDK1 inhibitor; structure in first sourceindazoles
fuscinfuscin: antibacterial pigment produced by the fungus Didiodendron fuscom; minor descriptor (75-82); online & Index Medicus search BENZOPYRANS (75-82)